Robert E Marcus
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 69
- Genetics 38
- Chronic Lymphocytic Leukemia Research 29
- Co-authors
- J. Andrew Bradley (4 shared papers)Anna L. Taylor (2 shared papers)Anton Hagenbeek (10 shared papers)Eva K. Kimby (10 shared papers)Martine Van Glabbeke (7 shared papers)E. R. Huehns (5 shared papers)Richard John Klasa (6 shared papers)Marinus H. J. van Oers (6 shared papers)
- Journals
- Blood (22 papers)Journal of Clinical Oncology (13 papers)British Journal of Haematology (13 papers)The Lancet (9 papers)Hematological Oncology (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Robert E Marcus
170 papers receiving 7.2k citations
Robert E Marcus's Hit Papers
Peers
Comparison fields: 5 of 153
- Pathology and Forensic Medicine 3.3k
- Genetics 1.9k
- Oncology 2.8k
- Hematology 1.2k
- Neurology 771
Countries citing papers authored by Robert E Marcus
This map shows the geographic impact of Robert E Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E Marcus more than expected).
Fields of papers citing papers by Robert E Marcus
This network shows the impact of papers produced by Robert E Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E Marcus. The network helps show where Robert E Marcus may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E Marcus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obinutuzumab for the First-Line Treatment of Follicular Lymphoma Hit paper breakdown → | 2017 | 531 |
| 2 | 2006 | 471 | |
| 3 | Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma Hit paper breakdown → | 2008 | 458 |
| 4 | 2001 | 360 | |
| 5 | 1986 | 341 | |
| 6 | 2005 | 313 | |
| 7 | 2010 | 239 | |
| 8 | 1983 | 233 | |
| 9 | 1998 | 207 | |
| 10 | 2010 | 170 | |
| 11 | 2010 | 170 | |
| 12 | 2018 | 158 | |
| 13 | 2007 | 157 | |
| 14 | 1998 | 155 | |
| 15 | 1999 | 126 | |
| 16 | 2012 | 121 | |
| 17 | 2013 | 107 | |
| 18 | 1991 | 104 | |
| 19 | 1984 | 93 | |
| 20 | 2018 | 82 |
About Robert E Marcus
Robert E Marcus is a scholar working on Pathology and Forensic Medicine, Genetics, Hematology, Oncology and Immunology, having authored 172 papers that have together received 7.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (69 papers), Viral-associated cancers and disorders (30 papers), Chronic Lymphocytic Leukemia Research (29 papers), Acute Myeloid Leukemia Research (18 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Hematopoietic Stem Cell Transplantation (14 papers), Immune Cell Function and Interaction (10 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.3k citations), Genetics (1.9k citations), Oncology (2.8k citations), Hematology (1.2k citations) and Neurology (771 citations). Robert E Marcus has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include J. Andrew Bradley, Anna L. Taylor, Anton Hagenbeek, Eva K. Kimby, Martine Van Glabbeke, E. R. Huehns, Richard John Klasa, Marinus H. J. van Oers, Max M. Wolf and Wolfgang Hiddemann. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, The Lancet and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.